1st Speaker
Kleine Levin Syndrome:  Is There a Happilty Ever After for Sleeping Beauty Syndrome?

Eliza Sukiennik, M.D.

Introduction
Dr. Sukiennik completed her undergraduate training at Loyola University in Chicago and went on to earn her medical degree from Poznan University of Medical Sciences in Poznan, Poland. She is board certified in General Adult Psychiatry and is currently a Child and Adolescent Psychiatry Fellow in her 5th year of training at Mayo Clinic. Following completion of her fellowship training in June 2017, Dr. Sukiennik will be returning to her home town, Chicago, to provide psychiatric care for a broad spectrum of psychiatric disorders.

Learning Objectives

1. Describe Kleine Levin Syndrome including typical/atypical presentations and outcomes.
2. Define psychiatrists' role in treatment of Kleine Levin Syndrome.

2nd Speaker
PACS Scores and Sobriety After Residential Chemical Dependency Treatment

Matthew Stohs, M.D.

Introduction
Dr. Stohs received his B.S. in Biology from Valparaiso University in 2006.  He later earned his M.D. from Tulane University in New Orleans, Louisiana in 2012.  He completed his psychiatry residency at Mayo Clinic in 2016 and is board certified in general psychiatry.  He is currently completing his addiction psychiatry fellowship at Mayo Clinic as well.  He will begin a faculty position at the Medical College of Wisconsin (MCW) in July of 2017 in a dual appointment at both MCW and Milwaukee VA Medical Center.  His clinical interests include treating addiction in the adolescent and young adult population as well as integrating psychiatric care into primary care settings.

Learning Objectives

1. Recognize the clinical significance of assessing alchohol craving.
2. Describe the relationship between alcohol craving severity and its relationsnip to return to drinking after treatment. 

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements
• Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.
• Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Activities, Pending activities, click Session title and Take Course to access the required Evaluation.
-or-
Click the Take Course button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Speakers:  Eliza Sukiennik, M.D. and Matthew Stohs, M.D.

Relevant financial relationship(s) with industry: 
None

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, M.D., Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Charlene Nelson

Speakers:  Lauren Murphy, D.O. and Ewa Bieber, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None